XML 105 R92.htm IDEA: XBRL DOCUMENT
v3.22.2

Fair Value (Quantitative Information) (Details) | Jun. 30, 2022 | Dec. 31, 2021
--- | --- | ---
Minimum | Interest rate | Measurement Input, Swap Yield |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 299 | 151
Minimum | Interest rate | Measurement Input, Price Volatility |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 0.01 | 0.01
Minimum | Foreign currency exchange rate | Measurement Input, Swap Yield |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 29 | 2
Minimum | Credit | Measurement Input, Credit Spread |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 85 | 96
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Mortality rates: Ages 0 - 40 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0 | 0
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Mortality rates: Ages 41 - 60 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0003 | 0.0003
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Mortality rates: Ages 61 - 115 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0012 | 0.0012
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Lapse rates: Durations 1 - 10 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0 | 0.0025
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Lapse rates: Durations 11 - 20 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0050 | 0.0050
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Lapse rates: Durations 21 - 116 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0050 | 0.0050
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Measurement Input, Utilization Rate |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0 | 0
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Measurement Input, Withdrawal Rate |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0 | 0
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Measurement Input, Long-Term Equity Volatility |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0874 | 0.0769
Minimum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Nonperformance risk spread |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0010 | 0.0004
Minimum | U.S. corporate and foreign corporate | Valuation Technique, Matrix Pricing | Measurement Input, Offered Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 0 | 1
Minimum | U.S. corporate and foreign corporate | Valuation Technique, Market Approach | Measurement Input, Quoted Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 20 | 0
Minimum | U.S. corporate and foreign corporate | Valuation Technique, Consensus Pricing Model | Measurement Input, Offered Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 95 | 99
Minimum | RMBS | Valuation Technique, Market Approach | Measurement Input, Quoted Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 0 | 0
Minimum | ABS & CLO | Valuation Technique, Market Approach | Measurement Input, Quoted Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 3 | 3
Maximum | Interest rate | Measurement Input, Swap Yield |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 317 | 200
Maximum | Interest rate | Measurement Input, Price Volatility |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 0.01 | 0.01
Maximum | Foreign currency exchange rate | Measurement Input, Swap Yield |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 1,938 | 305
Maximum | Credit | Measurement Input, Credit Spread |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 148 | 133
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Mortality rates: Ages 0 - 40 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0017 | 0.0017
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Mortality rates: Ages 41 - 60 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0075 | 0.0075
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Mortality rates: Ages 61 - 115 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 1 | 1
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Lapse rates: Durations 1 - 10 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 1 | 1
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Lapse rates: Durations 11 - 20 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 1 | 1
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Lapse rates: Durations 21 - 116 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 1 | 1
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Measurement Input, Utilization Rate |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.22 | 0.22
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Measurement Input, Withdrawal Rate |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.20 | 0.20
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Measurement Input, Long-Term Equity Volatility |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.25 | 0.25
Maximum | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Nonperformance risk spread |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0190 | 0.0145
Maximum | U.S. corporate and foreign corporate | Valuation Technique, Matrix Pricing | Measurement Input, Offered Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 132 | 165
Maximum | U.S. corporate and foreign corporate | Valuation Technique, Market Approach | Measurement Input, Quoted Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 126 | 117
Maximum | U.S. corporate and foreign corporate | Valuation Technique, Consensus Pricing Model | Measurement Input, Offered Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 101 | 104
Maximum | RMBS | Valuation Technique, Market Approach | Measurement Input, Quoted Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 117 | 121
Maximum | ABS & CLO | Valuation Technique, Market Approach | Measurement Input, Quoted Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 104 | 110
Weighted Average | Interest rate | Measurement Input, Swap Yield |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 310 | 188
Weighted Average | Interest rate | Measurement Input, Price Volatility |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 0.01 | 0.01
Weighted Average | Foreign currency exchange rate | Measurement Input, Swap Yield |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 204 | 134
Weighted Average | Credit | Measurement Input, Credit Spread |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Derivative Asset (Liability) Net, Measurement Input | 112 | 109
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Mortality rates: Ages 0 - 40 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0008 | 0.0008
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Mortality rates: Ages 41 - 60 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0027 | 0.0027
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Mortality rates: Ages 61 - 115 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0207 | 0.0208
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Lapse rates: Durations 1 - 10 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0624 | 0.0630
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Lapse rates: Durations 11 - 20 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0518 | 0.0522
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Lapse rates: Durations 21 - 116 |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0518 | 0.0522
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Measurement Input, Utilization Rate |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0022 | 0.0022
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Measurement Input, Withdrawal Rate |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0370 | 0.0372
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Measurement Input, Long-Term Equity Volatility |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.1860 | 0.1860
Weighted Average | Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | Nonperformance risk spread |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Embedded derivatives direct, assumed and ceded guaranteed minimum benefits | 0.0035 | 0.0035
Weighted Average | U.S. corporate and foreign corporate | Valuation Technique, Matrix Pricing | Measurement Input, Offered Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 91 | 109
Weighted Average | U.S. corporate and foreign corporate | Valuation Technique, Market Approach | Measurement Input, Quoted Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 94 | 100
Weighted Average | U.S. corporate and foreign corporate | Valuation Technique, Consensus Pricing Model | Measurement Input, Offered Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 98 | 100
Weighted Average | RMBS | Valuation Technique, Market Approach | Measurement Input, Quoted Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 93 | 99
Weighted Average | ABS & CLO | Valuation Technique, Market Approach | Measurement Input, Quoted Price |  |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] |  |
Debt Securities, Available-for-sale, Measurement Input | 94 | 102

X
- Definition Value of input used to measure investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of input used to measure net derivative asset (liability). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_DerivativeAssetLiabilityNetMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of input used to measure net embedded derivative asset (liability). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_EmbeddedDerivativeAssetLiabilityNetMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=met_MeasurementInputSwapYieldMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CreditRiskContractMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=met_MortalityRatesRangeOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=met_MortalityRatesRangeTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=met_MortalityRatesRangeThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=met_LapseRatesDurationRangeOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=met_LapseRatesDurationRangeTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=met_LapseRatesDurationRangeThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputUtilizationRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputWithdrawalRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=met_MeasurementInputLongTermEquityVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCounterpartyCreditRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueMatrixPricingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOfferedPriceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputQuotedPriceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueConsensusPricingModelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_WeightedAverageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |